Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Laboratory Corporation of America (LH) PT Raised to $260 at BofA Securities
August 5, 2024 5:41 AM EDTBofA Securities analyst Derik de Bruin raised the price target on Laboratory Corporation of America (NYSE: LH) to $260.00 (from $240.00) while maintaining a Buy rating.
The analyst comments "Much of the call focused on LCD margin dynamics, including Invitae contribution. Core LCD is executing... More
